Recurrent inactivating RASA2 mutations in melanoma
Rand Arafeh(Weizmann Institute of Science), Yardena Samuels(Weizmann Institute of Science), Nicola Waddell(QIMR Berghofer Medical Research Institute), Sivasish Sindiri(National Institutes of Health), Ron Rotkopf(Weizmann Institute of Science), Javed Khan(Kent State University), Jason Madore(QIMR Berghofer Medical Research Institute), Masha Y. Niv(Hebrew University of Jerusalem), Yael Hevroni(Weizmann Institute of Science), Ken Dutton‐Regester(Broad Institute), Jimmy Lin(Freenome (United States)), Nicholas K. Hayward(QIMR Berghofer Medical Research Institute), Victoria Hill(National Institutes of Health), Shifra Ben‐Dor(Weizmann Institute of Science), Peter A. Johansson(AstraZeneca (Sweden)), Antonia L. Pritchard(QIMR Berghofer Medical Research Institute), Steven A. Rosenberg(National Cancer Institute), Antonella Di Pizio(Center for Integrated Protein Science Munich), Nouar Qutob(Weizmann Institute of Science), Richard A. Scolyer(The University of Sydney), Rafi Emmanuel(Weizmann Institute of Science), Alona Keren‐Paz(Icahn School of Medicine at Mount Sinai), Graham J. Mann(Murdoch University), Igor Ulitsky(Weizmann Institute of Science), Sabina Winograd‐Katz(Weizmann Institute of Science), Jared J. Gartner(National Institutes of Health), Abdel G. Elkahloun(National Institutes of Health), James S. Wilmott(The University of Sydney)
Cited by 107
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k